(lp0
S"Intercept Pharmaceuticals Inc  Stock Could Be Biotech's Grand Slam Investorplace.com - Jan 24, 2017 The market has begun 2017 trading sideways, but don't let that fool you into thinking there aren't opportunities out there, especially in biotech."
p1
aS'Decision Time: Intercept Pharmaceuticals Inc  Stock Technicals ... CML News - 12 hours ago Decision Time: Intercept Pharmaceuticals Inc  now sits in the perhaps the most difficult technical position -- the stock has no urgency in its direction and that has left it at an inflection point.'
p2
aS"This Analyst Bullish On Intercept Pharmaceuticals Inc  Long-Term Smarter Analyst - Feb 10, 2017 Intercept Pharmaceuticals Inc  shares rose as much as 9% during Friday's trading session, after the drug maker announced changes to its ongoing Ocaliva Phase 3 trial in NASH that increase probability of completing enrollment for interim&nbsp;...Intercept Pharma  to Provide Update on Phase 3 REGENERATE Trial of OCA ... - StreetInsider.comIs Intercept Pharmaceuticals Inc  Stock A Buy After OCA Update? - BNL Finance   "
p3
aS'Intercept Pharmaceuticals Inc  Receives $176.25 Average Target Price ... The Cerbat Gem - Mar 19, 2017 Intercept Pharmaceuticals logo Intercept Pharmaceuticals Inc  has been given a consensus recommendation of Hold by the twenty analysts that are presently covering the firm.'
p4
aS'Charles Payne on Biotech: Biogen Inc , Intercept Pharmaceuticals Inc  Investorplace.com - Nov 29, 2016 Still, I am not interested in chasing drug names, as most of the large pharmaceutical companies have thin product pipelines and aging blockbusters.'
p5
aS'Stock Alert and Holding Pattern: Intercept Pharmaceuticals Inc Price ... CML News - Mar 17, 2017 Before we cover the full analysis we make a quick alert here that Intercept Pharmaceuticals Inc  has seen its stock price move at an amplified level.'
p6
aS"Blog Coverage Intercept Pharmaceuticals Received NICE Approval for Ocaliva for ... Yahoo Finance - Mar 3, 2017 LONDON, UK / ACCESSWIRE / March 3, 2017 / Active Wall St. blog coverage looks at the headline from Intercept Pharmaceuticals, Inc.  as the Company announced on March 01, 2017, that UK's National Institute for Health and Care&nbsp;..."
p7
aS"Intercept Pharmaceuticals Reports Third Quarter 2016 Financial Results and ... GlobeNewswire  - Nov 3, 2016 NEW YORK, Nov. 03, 2016  -- Intercept Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases, today&nbsp;...Intercept Pharmaceuticals'  CEO Mark Pruzanski on Q3 2016 Results ... - Seeking AlphaIntercept  Reports Narrower-Than-Expected Q3 Loss November 03, 2016 - Zacks.com"
p8
aS"Intercept Pharmaceuticals Inc.  Moves Higher on Volume Spike for February 13 Equities.com - Feb 13, 2017 Intercept Pharmaceuticals Inc.  traded on unusually high volume on Feb. 13, as the stock gained 3.47% to close at $122.62.Sizling Stock Update: Intercept Pharmaceuticals, Inc.  - HugoPressHealthcare Most Traded Stock: Intercept Pharmaceuticals, Inc.'s  - Is stories"
p9
aS'Intercept Pharmaceuticals Reports Full Year 2016 Financial Results and ... GlobeNewswire  - Feb 23, 2017 NEW YORK, Feb. 23, 2017  -- Intercept Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today&nbsp;...Intercept Pharmaceuticals  Q4 2016 Results - Earnings Call Transcript - Seeking AlphaINTERCEPT PHARMACEUTICALS, INC.  Files An 8-K Results of ... - Market Exclusive'
p10
a.